These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

929 related items for PubMed ID: 8080242

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
    Fitzmaurice PS, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ.
    Mov Disord; 2003 Sep; 18(9):969-76. PubMed ID: 14502663
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
    Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Daniel SE, Lees AJ, Schapira AH.
    Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590
    [Abstract] [Full Text] [Related]

  • 7. Oxidative stress in Parkinson's disease and other neurodegenerative disorders.
    Jenner P.
    Pathol Biol (Paris); 1996 Jan; 44(1):57-64. PubMed ID: 8734302
    [Abstract] [Full Text] [Related]

  • 8. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
    Hardman CD, Halliday GM.
    Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
    [Abstract] [Full Text] [Related]

  • 9. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD, Halliday GM, McRitchie DA, Cartwright HR, Morris JG.
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [Abstract] [Full Text] [Related]

  • 10. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ, Ofori E, Pasternak O, Burciu RG, Shukla P, DeSimone JC, Okun MS, McFarland NR, Vaillancourt DE.
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [Abstract] [Full Text] [Related]

  • 11. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L, Wang J, Zhao L, Jin H, Fei G, Zhang Y, Zeng M, Zhong C.
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [Abstract] [Full Text] [Related]

  • 12. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [Abstract] [Full Text] [Related]

  • 13. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
    Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, Guttman M, Hornykiewicz O, Kish SJ.
    Brain; 2017 Sep 01; 140(9):2460-2474. PubMed ID: 29050386
    [Abstract] [Full Text] [Related]

  • 14. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
    Martínez-Mir MI, Pollard H, Moreau J, Traiffort E, Ruat M, Schwartz JC, Palacios JM.
    Synapse; 1993 Nov 01; 15(3):209-20. PubMed ID: 7904088
    [Abstract] [Full Text] [Related]

  • 15. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P, Lévesque M, Parent A.
    Brain; 2007 Jan 01; 130(Pt 1):222-32. PubMed ID: 17142832
    [Abstract] [Full Text] [Related]

  • 16. [Aluminum deposition in the central nervous system tissues of patients with Parkinson's disease].
    Yasui M, Kihira T, Ota K, Mukoyama M, Adachi K.
    Rinsho Shinkeigaku; 1991 Oct 01; 31(10):1095-8. PubMed ID: 1802464
    [Abstract] [Full Text] [Related]

  • 17. Calbindin-D28k in the basal ganglia of patients with parkinsonism.
    Ito H, Goto S, Sakamoto S, Hirano A.
    Ann Neurol; 1992 Oct 01; 32(4):543-50. PubMed ID: 1456738
    [Abstract] [Full Text] [Related]

  • 18. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
    Geng DY, Li YX, Zee CS.
    Neurosurgery; 2006 Feb 01; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
    [Abstract] [Full Text] [Related]

  • 19. [125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys.
    Villares J, Faucheux B, Herrero MT, Obeso JA, Duyckaerts C, Hauw JJ, Agid Y, Hirsch EC.
    Exp Neurol; 1998 Nov 01; 154(1):146-56. PubMed ID: 9875276
    [Abstract] [Full Text] [Related]

  • 20. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, Cortelli P, Malucelli E, Capellari S, Testa C, Parchi P, Montagna P, Barbiroli B, Lodi R.
    Brain; 2008 Oct 01; 131(Pt 10):2690-700. PubMed ID: 18819991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.